Ignite Creation Date:
2024-07-17 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06476197
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-05-27
Brief Title:
Exploratory Clinical Trial to Safety and Efficacy of SAT-003 in Cancer Cachexia Patients Discontinued Chemotherapy Who Had Diagnosed With Solid Cancer
Sponsor:
S-Alpha Therapeutics Inc
Organization:
S-Alpha Therapeutics Inc
Study Overview
Official Title:
A Single Center Single Arm Prospective Exploratory Clinical Trial to Evaluate the Validity Safety and Efficacy of SAT-003 in Cancer Cachexia Patients Discontinued Chemotherapy Who Had Diagnosed With Solid Cancer
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Although various studies and treatments for cachexia are being attempted there is currently no definitive treatment that can improve cancer cachexia symptoms Nutritional therapy for anorexia which is a primary symptoms of cachexia and medicatio therapy to improve appetite have limitations in effectively alleviating the overall symptoms of cachexia Cachexia initially manifests with symptoms such as loss of appetite and weight loss and gradually progresses skeletal muscle loss eventually leading to systemic dysfunction Consequently there is a steady increase in the development of related treatments
SAT-003 provides various activities aimed at improving the symptoms of cancer cachexia with the ultimate goal of resuming discontinued chemotherapy
SAT-003 provides various activities aimed at improving the symptoms of cancer cachexia with the ultimate goal of resuming discontinued chemotherapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None